Genetic Technologies Pre-Tax Profit Margin 2010-2022 | GENE
Genetic Technologies pre-tax profit margin from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Genetic Technologies Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.022B |
$0.005B |
|
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
|
